糖尿病合并外周动脉疾病患者从小截肢进展为大截肢的风险因素与临床轨迹
本研究为墨西哥5家三级中心的回顾性多中心队列研究,纳入2010至2025年因糖尿病合并外周动脉疾病接受小截肢的314例成人。184例(58.6%)进展为大截肢,中位时间1个月(IQR 1-4)。慢性肢体威胁性缺血(CLTI)是最强预测因子(aOR 9.79,95%CI 3.45-27.77,P<0.001)。
要点
- 小截肢后大截肢进展率高(58.6%),且发生早,中位1个月。
- CLTI、小截肢近端水平、慢性肾病和吸烟史独立增加大截肢风险。
- 既往血运重建与进展风险降低相关但未达统计显著(aOR 0.41,P=0.054)。
核心结论
- 糖尿病合并PAD患者小截肢后进展为大截肢常见且发生早,CLTI、近端小截肢水平、慢性肾病和吸烟史识别高危患者。
研究设计与样本
- 回顾性多中心队列研究,纳入2010-2025年墨西哥城5家三级中心因DM合并PAD接受小截肢的314例成人。
主要发现
- 314例小截肢患者中184例(58.6%)进展为大截肢,中位时间1个月(IQR 1-4)。
- CLTI是最强预测因子(aOR 9.79,95%CI 3.45-27.77,P<0.001)。
- 小截肢近端水平独立相关(aOR 4.18,95%CI 1.56-11.19,P=0.04)。
- 慢性肾病(aOR 3.68,95%CI 1.47-9.20,P=0.005)和吸烟史(aOR 2.42,95%CI 1.14-5.13,P=0.021)为显著风险因素。
- 既往血运重建与进展风险降低相关但未达统计显著(aOR 0.41,95%CI 0.16-1.02,P=0.054)。
关键数值与推荐
- 小截肢后大截肢进展率58.6%(184/314),中位时间1个月(IQR 1-4)。
- CLTI的aOR 9.79(95%CI 3.45-27.77,P<0.001);近端小截肢水平aOR 4.18(95%CI 1.56-11.19,P=0.04)。
- 慢性肾病aOR 3.68(95%CI 1.47-9.20,P=0.005);吸烟史aOR 2.42(95%CI 1.14-5.13,P=0.021)。
- 既往血运重建aOR 0.41(95%CI 0.16-1.02,P=0.054)。
临床怎么用
- 对DM合并PAD小截肢患者应早期评估大截肢风险,尤其CLTI、近端截肢、慢性肾病和吸烟者。
- 需加强风险分层并制定个体化保肢管理策略以降低早期大截肢进展。
局限性
- 回顾性设计可能引入选择偏倚和信息偏倚。
- 仅纳入墨西哥城5家三级中心,外推性受限。
- 既往血运重建与进展风险降低相关未达统计显著(P=0.054)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minor lower extremity (LE) amputation is commonly performed in patients with diabetes mellitus (DM) and peripheral arterial disease (PAD) as part of limb preservation strategies; however, progression to major amputation remains frequent in Mexico. We aim to study and characterize factors associated with progression to major amputations. METHODS: We completed a retrospective multicenter cohort study of adults with DM and PAD who underwent minor LE amputation between 2010 and 2025 at 5 tertiary referral centers in Mexico City. The primary outcome was progression to major amputation, reamputation, and mortality; and multivariable logistic regression was used to identify independent predictors. RESULTS: Among 314 patients undergoing minor amputation, 184 (58.6%) progressed to major amputation, with a median time of 1 month (interquartile range (IQR [1-4]). Chronic limb-threatening ischemia (CLTI) was the strongest predictor of major amputation (adjusted odds ratio [aOR] 9.79, 95% confidence interval [CI], 3.45-27.77, P < 0.001). A proximal level of the index minor amputation was also independently associated with major limb loss (aOR 4.18, 95% CI, 1.56-11.19, P = 0.04). Chronic kidney disease (aOR 3.68, 95% CI, 1.47-9.20, P = 0.005) and smoking history (aOR 2.42, 95% CI, 1.14-5.13, P = 0.021) were additional significant risk factors. Prior revascularization was associated with a nonstatistically significant lower risk of progression (aOR 0.41, 95% CI, 0.16-1.02, P = 0.054). CONCLUSIONS: Progression to major amputation after minor amputation is common and occurs early in patients with DM and PAD. CLTI, proximal minor amputation level, chronic kidney disease, and smoking identify patients at particularly high risk, underscoring the need for improved risk stratification and tailored limb management strategies.
引用
- Hinojosa CA, Ricardo AC, Del Valle DD, et al. Progression from Minor to Major Amputation in Patients with Diabetes and Peripheral Arterial Disease: Risk Factors and Clinical Trajectories. Ann Vasc Surg. 2026. PMID: 42276369. doi:10.1016/j.avsg.2026.05.105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。